Credit for this activity will be provided through October 4, 2014. There is no fee for participating in this activity.
Sponsored by the Center for Continuing and Outreach Education at Rutgers
Biomedical and Health Sciences and New York/New Jersey AIDS Education
and Training Center (NY/NJ AETC).
Funding for this activity is provided by the Health Resources and Services Administration (HRSA).
This video was originally recorded July 2012 and updated August 2013.
Physicians, Physician Assistants, Nurse Practitioners, Nurses, and other Primary Care Clinicians.
Program Description and Overall Goal
This activity was designed for HIV clinical providers as part of the comprehensive Cervical Pap Test Training Program for Clinical Providers. The goal of the program is to provide clinicians with the knowledge, skills, and support to appropriately perform cervical Pap tests and pelvic exams for HIV positive women as recommended by national guidelines, reduce the barriers for clinicians and patients associated with lower cervical Pap test rates, and ultimately, to improve clinical rates of Pap tests performed among HIV positive women.
Pap Test and Pelvic Examination Training
To participate in the FULL, 3-part, Cervical Pap Test Training Program for Clinical Providers, participants must complete all the components of the program listed below:
- Participant completion of the online presentation on Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination
- Participant completion of a skills-building session with simulated patient models (1-3 hours)
- Participant completion of cervical cancer screening preceptorship with observation and hands-on experience (4-8 Hours in 1-2 sessions)
To enroll in the FULL, 3-part, Cervical Pap Test Training Program for Clinical Providers, please contact email@example.com.
|Note: Participants may choose to only participate in the archived presentation outlined on this page, Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination.
Course Goals and Objectives
This continuing education activity is designed to enhance the ability of HIV care providers to perform cervical Pap tests and pelvic examinations.
At the conclusion of this activity, the participant should be able to:
- Identify guidelines for cervical cancer screening in HIV-infected women.
- Recognize the most recent Bethesda system.
- Describe techniques utilized in cervical Pap smear sampling.
- Discuss and review the complete pelvic examination.
- Analyze the algorithm for follow-up and referral of abnormal cervical Pap smears in HIV-infected women.
Method of Participation
To receive CE credit for participation in the Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination presentation please complete the following participation survey in its entirety. The survey includes a registration page, post-test, activity evaluation form and Participant Information Form (PIF). Participants must complete the post-test at a level of 75% proficiency. After completion of the survey, participants will be able to print a CE certificate instantly online.
CLICK HERE to access the online Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination presentation.
After viewing the online presentation, CLICK HERE to complete the participation surveys and receive your CE certificate.
activity has been planned and implemented in accordance with the
Essential Areas and Policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of Rutgers, The
State University of New Jersey and NY/NJ AETC. Rutgers, The State University of New Jersey is accredited by the ACCME to provide continuing medical education for physicians.
Rutgers, The State University of New Jersey designates this enduring material for a maximum of
0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Rutgers, The State University of New Jersey Center of Continuing and Outreach Education is an approved provider of continuing nursing education by New Jersey
State Nurses Association, an accredited approver by the American Nurses
Credentialing Center’s Commission on Accreditation. Provider Number P173-12/12-15.
This activity is awarded 0.75 contact hours. (60 minute CH)
The estimated time to complete this activity is 45 minutes.
Katie Carroll, MPH
New York/New Jersey AETC
Kim Choma, RN, DNP, WHNP
Rutgers, The State
University of New Jersey
Private Practice, Summit, NJ
Nina Regevik, MD, FAACP
Raritan Bay Medical Center
|Anna M. Haywood, RN, MSN; FXB of Rutgers, The State University of New Jersey
||Daria Boccher-Lattimore, DrPH;
NY/NJ AIDS Education and Training Center
|Dawn Slowinski, RN, BSN, MSN, PHCNS-BC; Garden State Infectious Disease Association
||Deb M. Winters, APRN‐BC, AACRN; ID Care
|Elizabeth Ward, MSJ; Center for Continuing and Outreach Education at Rutgers Biomedical and Health Sciences
||Jeffrey Kwong, DNP, MPH, ANP-BC; Columbia University School of Nursing
|Katie Carroll, MPH;
NY/NJ AIDS Education and Training Center
||Mari Millery, PhD; NY/NJ AIDS Education and Training Center
|Nadine Nader, NY/NJ AIDS Education and Training Center
||Shanon Levine, NY/NJ AIDS Education and Training Center
|Zeneida Cruz, MA; Raritan Bay Medical Center
Peer Review Statement
In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, CCOE has resolved all potential and real conflicts of interest through content review by a non-conflicted, qualified reviewer. This activity was peer-reviewed for relevance, accuracy of content and balance of presentation by Judith Lightfoot, DO, FACOI; Garden State Infectious Disease Association.
In accordance with the disclosure policies of Rutgers, and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
Nina Regevik, MD, FAACP has disclosed the following relevant financial relationships: Consultant, Gilead.
Kim Choma, RN, DNP, WHNP, has no relevant financial relationships to disclose.
Judith Lightfoot, DO, FACOI has no relevant financial relationships to disclose.
Planning Committee members Anna M. Haywood, RN, MSN; Daria Boccher-Lattimore, DrPH; Dawn Slowinski, RN, BSN, MSN, PHCNS-BC; Deb M. Winters, APRN‐BC, AACRN; Elizabeth Ward, MSJ; Jeffrey Kwong, DNP, MPH, ANP-BC; Katie Carroll, MPH; Mari Millery, PhD; Nadine Nader; Shanon Levine; and Zeneida Cruz, MA; have no relevant financial relationships to disclose.
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Viewing the Presentation
Make sure you have the latest version of Adobe Flash Player installed on your computer. If the problem persists, please let us know. If you do not have Adobe Flash Player, you can download this free plug-in from Adobe.com.
The presentation is best viewed at a resolution of 1024 x 768 or higher using Microsoft Internet Explorer 8 or later. A high-speed Internet connection, such as ISDN, T-1, DSL or Cable, is recommended.
Adobe Flash Player 6 software or later is recommended, along with a standard web browser including the following (the stated version or later): Internet Explorer 8, Firefox 3.x, or Safari 4.
Contact Information for Technical Questions
Please direct technical questions to Katie Carroll, firstname.lastname@example.org, NY/NJ AETC.
Provider Contact Information
Please direct content or CE related questions or concerns to Rutgers at 973-972-4267 or email email@example.com.
The views expressed in this activity are those of the faculty.
It should not be inferred or assumed that they are expressing the views of the Health Resources and Services Administration (HRSA), or NY/NJ AETC, or Rutgers.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. Participants are urged to consult all available data on products or procedures before using them in clinical practice.
Policy on Privacy and Confidentiality
Email firstname.lastname@example.org with questions, comments, or problems.
See NY/NJ AETC disclaimer for usage guidelines.